MRNS
Marinus Pharmaceuticals Inc
Price:  
9.54 
USD
Volume:  
310,153.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

MRNS EV/EBITDA

-387.9%
Upside

As of 2024-03-05, the EV/EBITDA ratio of Marinus Pharmaceuticals Inc (MRNS) is -3.64. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MRNS's latest enterprise value is 452.70 mil USD. MRNS's TTM EBITDA according to its financial statements is -124.36 mil USD. Dividing these 2 quantities gives us the above MRNS EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 8.5x - 11.1x 9.3x
Forward P/E multiples 11.9x - 19.7x 15.9x
Fair Price (25.83) - (24.14) (27.47)
Upside -370.7% - -353.1% -387.9%
9.54 USD
Stock Price
(27.47) USD
Fair Price

MRNS EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-03-04 -3.64
2024-03-01 -3.81
2024-02-29 -3.62
2024-02-28 -3.78
2024-02-27 -3.84
2024-02-26 -3.84
2024-02-23 -3.74
2024-02-22 -3.68
2024-02-21 -3.73
2024-02-20 -3.64
2024-02-16 -3.82
2024-02-15 -3.84
2024-02-14 -3.85
2024-02-13 -3.80
2024-02-12 -3.93
2024-02-09 -3.89
2024-02-08 -3.84
2024-02-07 -3.80
2024-02-06 -3.84
2024-02-05 -3.82
2024-02-02 -3.83
2024-02-01 -3.84
2024-01-31 -3.73
2024-01-30 -3.84
2024-01-29 -3.91
2024-01-26 -3.85
2024-01-25 -3.84
2024-01-24 -3.78
2024-01-23 -3.82
2024-01-22 -3.89
2024-01-19 -3.67
2024-01-18 -3.73
2024-01-17 -3.68
2024-01-16 -3.64
2024-01-12 -3.75
2024-01-11 -3.96
2024-01-10 -4.06
2024-01-09 -4.28
2024-01-08 -4.37
2024-01-05 -4.21
2024-01-04 -4.07
2024-01-03 -4.03
2024-01-02 -4.02
2023-12-29 -4.22
2023-12-28 -4.28
2023-12-27 -4.27
2023-12-26 -4.19
2023-12-22 -4.04
2023-12-21 -3.71
2023-12-20 -3.53